Recent Locoregional CAR T-Cell Trials for the Treatment of Recurrent Glioblastoma: Implications for Neuro-Oncology Practice.

Saved in:
Bibliographic Details
Title: Recent Locoregional CAR T-Cell Trials for the Treatment of Recurrent Glioblastoma: Implications for Neuro-Oncology Practice.
Authors: Etter MM; Department of Neurosurgery, University Hospital Basel, Basel, Switzerland. ettermanina@gmail.com.; Brain Tumor Immunotherapy and Biology Research Group, Department of Biomedicine, University of Basel, Basel, Switzerland. ettermanina@gmail.com., Akeret K; Department of Neurosurgery and Brain Repair, USF Morsani College of Medicine, Tampa, FL, USA.; Department of Neurosurgery, Clinical Neuroscience Centre, University Hospital Zurich and University of Zurich, Zurich, Switzerland., Guzman R; Department of Neurosurgery, University Hospital Basel, Basel, Switzerland., Mariani L; Department of Neurosurgery, University Hospital Basel, Basel, Switzerland.; Brain Tumor Immunotherapy and Biology Research Group, Department of Biomedicine, University of Basel, Basel, Switzerland., Hutter G; Department of Neurosurgery, University Hospital Basel, Basel, Switzerland.; Brain Tumor Immunotherapy and Biology Research Group, Department of Biomedicine, University of Basel, Basel, Switzerland., Lim M; Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA, USA.
Source: CNS drugs [CNS Drugs] 2026 Jul 22. Date of Electronic Publication: 2026 Jul 22.
Publication Type: Journal Article; Review
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9431220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1934 (Electronic) Linking ISSN: 11727047 NLM ISO Abbreviation: CNS Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1179-1934
DOI:10.1007/s40263-026-01322-8